CHARM Therapeutics Email Format
Biotechnology ResearchEngland, United Kingdom11-50 Employees
CHARM Therapeutics is a biotechnology research company headquartered in London, England. Its lead program targets a menin inhibitor for AML, designed to address resistance mutations that undermine first-generation agents. The approach aims to preserve potency across known clinical resistance variants, with the goal of delivering more durable responses for patients.